Impact of IQ on the diagnostic yield of chromosomal microarray in a community sample of adults with schizophrenia

Abstract

BackgroundSchizophrenia is a severe psychiatric disorder associated with IQ deficits. Rare copy number variations (CNVs) have been established to play an important role in the etiology of schizophrenia. Several of the large rare CNVs associated with schizophrenia have been shown to negatively affect IQ in population-based controls where no major neuropsychiatric disorder is reported. The aim of this study was to examine the diagnostic yield of microarray testing and the functional impact of genome-wide rare CNVs in a community ascertained cohort of adults with schizophrenia and low (< 85) or average (≥ 85) IQ.MethodsWe recruited 546 adults of European ancestry with schizophrenia from six community psychiatric clinics in Canada. Each individual was assigned to the low or average IQ group based on standardized tests and/or educational attainment. We used rigorous methods to detect genome-wide rare CNVs from high-resolution microarray data. We compared the burden of rare CNVs classified as pathogenic or as a variant of unknown significance (VUS) between each of the IQ groups and the genome-wide burden and functional impact of rare CNVs after excluding individuals with a pathogenic CNV.ResultsThere were 39/546 (7.1%; 95% confidence interval [CI] = 5.2–9.7%) schizophrenia participants with at least one pathogenic CNV detected, significantly more of whom were from the low IQ group (odds ratio [OR] = 5.01 [2.28–11.03], p = 0.0001). Secondary analyses revealed that individuals with schizophrenia and average IQ had the lowest yield of pathogenic CNVs (n = 9/325; 2.8%), followed by those with borderline intellectual functioning (n = 9/130; 6.9%), non-verbal learning disability (n = 6/29; 20.7%), and co-morbid intellectual disability (n = 15/62; 24.2%). There was no significant difference in the burden of rare CNVs classified as a VUS between any of the IQ subgroups. There was a significantly (p=0.002) increased burden of rare genic duplications in individuals with schizophrenia and low IQ that persisted after excluding individuals with a pathogenic CNV.ConclusionsUsing high-resolution microarrays we were able to demonstrate for the first time that the burden of pathogenic CNVs in schizophrenia differs significantly between IQ subgroups. The results of this study have implications for clinical practice and may help inform future rare variant studies of schizophrenia using next-generation sequencing technologies.Electronic supplementary materialThe online version of this article (doi:10.1186/s13073-017-0488-z) contains supplementary material, which is available to authorized users.

Elucidating the diagnostic odyssey of 22q11.2 deletion syndrome

“…One could imagine that genome-wide microarrays, not requiring an index of suspicion for a specific syndrome, should eventually change the landscape of molecular diagnosis, as implied by the results from the recent US pediatric cohort. However, the findings from the current study support those of other studies indicating that clinical uptake remains poor for individuals with DD/ID [Lowther et al, 2017; McKay et al, 2017; Mordaunt et al, 2014]. These DD/ID results thus provide further support for newborn screening.…”

Identifying schizophrenia patients who carry pathogenic genetic copy number variants using standard clinical assessment: retrospective cohort study

“…On the basis of their findings, the authors concluded that individuals with schizophrenia and low IQ should be prioritised for clinical microarray testing in clinical and research contexts. 25 We believe that our study provides further support for this recommendation, but that other developmental indices, which could be captured by a clinical neurodevelopmental history, should also be considered in the development of any future guidelines.…”

Improving access to genetic testing for adults with intellectual disability: A literature review and lessons from a quality improvement project in East London

“…Recent research found that around 10% of adults with presumed idiopathic intellectual disability presenting to psychiatric services had likely neurosusceptibilty variants, with deletions and duplications at 15q11‐q13 and 16p11.2‐p13.11 being most frequently observed (Wolfe et al, ). Other recent research has shown that patients with schizophrenia and neurosusceptibilty variants were significantly more likely to have lower IQs (Lowther et al, ).…”